fbpx

News

The Augurex team brings together leading scientific, clinical, technical and commercial expertise to ensure that our research translates into advanced diagnostics for improved patient outcomes.

Prev Next
New Day Diagnostics Collaboration

New Day Diagnostics Collaboration

Augurex and New Day Diagnostics Collaborate to Launch SPINEstat™, Revolutionizing Early Diagnosis and Management of Ankylosing Spondylitis Augurex and New Day Diagnostics Collaborate to Launch SPINEstat™, Revolutionizing Early Diagnosis and Management of Ankylosing...

read more
Augurex has received $5M in funding from PacifiCan

Augurex has received $5M in funding from PacifiCan

Government of Canada invests almost $14 million to drive innovation and economic growth in Vancouver.Today, the Honourable Mary Ng, Minister of Export Promotion, International Trade and Economic Development on behalf of the Honourable Harjit S. Sajjan, Minister of...

read more
14-3-3η: How Joint Involvement “Spreads”

14-3-3η: How Joint Involvement “Spreads”

14-3-3η: A Critical Mass of Data A recent systematic literature review describes a substantive body of evidence for 14-3-3η's clinically important role along the whole continuum of rheumatoid arthritis and autoimmune patient care.Key Statements:14-3-3η helps to assess...

read more
Commitment to Access, Quality and Growth through Innovation

Commitment to Access, Quality and Growth through Innovation

Dynacare Launches JOINTstat® Testing in Canada Augurex is pleased to announce the launch of JOINTstat (14-3-3ƞ) testing services through Dynacare, one of Canada’s largest and most established health solution companies with a dedicated mission to support healthy lives...

read more
14-3-3η: How Joint Involvement “Spreads”

14-3-3η: How Joint Involvement “Spreads”

14-3-3η: A Critical Mass of Data A recent systematic literature review describes a substantive body of evidence for 14-3-3η's clinically important role along the whole continuum of rheumatoid arthritis and autoimmune patient care.Key Statements:14-3-3η helps to assess...

read more
Commitment to Access, Quality and Growth through Innovation

Commitment to Access, Quality and Growth through Innovation

Dynacare Launches JOINTstat® Testing in Canada Augurex is pleased to announce the launch of JOINTstat (14-3-3ƞ) testing services through Dynacare, one of Canada’s largest and most established health solution companies with a dedicated mission to support healthy lives...

read more

Digital Technology Supercluster Member Spotlight

Did you miss the Digital Technology Supercluster Member Spotlight on Augurex?  Read how Augurex will be working alongside Supercluster members like Telus Health, Providence Health Care, Microsoft and LifeLabs Medical Laboratory Services to advance patient-centric...

read more
2018 Ready to Rocket Winner

2018 Ready to Rocket Winner

Honored to be recognized by "Ready to Rocket" as one of the 10 featured Life Sciences companies to experience accelerated growth. We're excited for the future! About Ready to Rocket: Ready to Rocket is a unique business recognition list that profiles technology...

read more

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Sign Up for Updates

* indicates required
Terms

Home

Products

Science

About

News

Careers

Contact

220 – 887 Great Northern Way
Vancouver, BC, V5T 4T5

Phone: 604.637.3280